Hendra virus.
Abstract: Hendra virus infection of horses occurred sporadically between 1994 and 2010 as a result of spill-over from the viral reservoir in Australian mainland flying-foxes, and occasional onward transmission to people also followed from exposure to affected horses. An unprecedented number of outbreaks were recorded in 2011 leading to heightened community concern. Release of an inactivated subunit vaccine for horses against Hendra virus represents the first commercially available product that is focused on mitigating the impact of a Biosafety Level 4 pathogen. Through preventing the development of acute Hendra virus disease in horses, vaccine use is also expected to reduce the risk of transmission of infection to people.
Crown Copyright © 2014. Published by Elsevier Inc. All rights reserved.
Publication Date: 2014-09-30 PubMed ID: 25281398PubMed Central: PMC4252762DOI: 10.1016/j.cveq.2014.08.004Google Scholar: Lookup The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- N.I.H.
- Extramural
- Research Support
- Non-U.S. Gov't
- Review
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research article discusses the development and impact of a vaccine to control the spread of Hendra virus from horses to humans. Originated from flying-foxes in Australia, Hendra virus posed a significant risk, leading to an increased number of outbreaks in 2011. However, a recently commercially available vaccine for horses against the virus is not only minimizing its impact but also cutting down human infection risk.
Overview of Hendra Virus and its Impact
- The Hendra virus was notably affecting horses who picked up the infection from Australian flying-foxes, the virus’s reservoir.
- These infected horses then occasionally transmitted the virus to people, leading to the occasional outbreaks of the disease in humans during the period from 1994 to 2010.
- This situation drastically changed in 2011 when an unprecedented number of outbreaks occurred, leading to heightened concerns in the affected communities.
Development and Implementation of the Vaccine
- In response to growing concerns, an inactivated subunit vaccine for horses against Hendra virus was commercially produced and released.
- This vaccine claims the landmark of being the first commercial product that aims to mitigate the impact of a Biosafety Level 4 pathogen, the category which includes some of the most dangerous pathogens for humans.
Impact of the Vaccine on Controlling the Spread of Hendra Virus
- The proactive vaccination of horses is not only intended to prevent the development of acute Hendra virus disease in these animals, but also significantly reduces the risk of transmitting the infection to humans.
- Theoretically, as more horses get vaccinated, fewer horses would get infected and, thus, the chances of the virus crossing over to humans would decrease.
Cite This Article
APA
Middleton D.
(2014).
Hendra virus.
Vet Clin North Am Equine Pract, 30(3), 579-589.
https://doi.org/10.1016/j.cveq.2014.08.004 Publication
Researcher Affiliations
- Australian Animal Health Laboratory, CSIRO, PB 24, Geelong, Victoria 3220, Australia. Electronic address: Deborah.middleton@csiro.au.
MeSH Terms
- Animals
- Australia / epidemiology
- Chiroptera / virology
- Hendra Virus / isolation & purification
- Henipavirus Infections / epidemiology
- Henipavirus Infections / veterinary
- Henipavirus Infections / virology
- Horse Diseases / epidemiology
- Horse Diseases / virology
- Horses
- Humans
- Zoonoses / epidemiology
- Zoonoses / virology
Grant Funding
- U01 AI077995 / NIAID NIH HHS
- U01-A107795 / PHS HHS
Conflict of Interest Statement
Dr Middleton: Nil
References
This article includes 42 references
- Murray K, Selleck P, Hooper P, Hyatt A, Gould A, Gleeson L, Westbury H, Hiley L, Selvey L, Rodwell B. A morbillivirus that caused fatal disease in horses and humans.. Science 1995 Apr 7;268(5207):94-7.
- Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PS, Ksiazek TG, Zaki SR, Paul G, Lam SK, Tan CT. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia.. Lancet 1999 Oct 9;354(9186):1257-9.
- Marsh GA, de Jong C, Barr JA, Tachedjian M, Smith C, Middleton D, Yu M, Todd S, Foord AJ, Haring V, Payne J, Robinson R, Broz I, Crameri G, Field HE, Wang LF. Cedar virus: a novel Henipavirus isolated from Australian bats.. PLoS Pathog 2012;8(8):e1002836.
- Symons R. Re: Canine case of Hendra virus and Hendra virus vaccine. Aust Vet J. 2011;89(10):N24.
- [Accessed March 14, 2014];Hendra Virus, equine u2013 Australia (18): (Queensland) canine. http://www.promedmail.org ProMed Arch No: 20130721.1837123.
- Playford EG, McCall B, Smith G, Slinko V, Allen G, Smith I, Moore F, Taylor C, Kung YH, Field H. Human Hendra virus encephalitis associated with equine outbreak, Australia, 2008.. Emerg Infect Dis 2010 Feb;16(2):219-23.
- O'Sullivan JD, Allworth AM, Paterson DL, Snow TM, Boots R, Gleeson LJ, Gould AR, Hyatt AD, Bradfield J. Fatal encephalitis due to novel paramyxovirus transmitted from horses.. Lancet 1997 Jan 11;349(9045):93-5.
- Tan CT, Goh KJ, Wong KT, Sarji SA, Chua KB, Chew NK, Murugasu P, Loh YL, Chong HT, Tan KS, Thayaparan T, Kumar S, Jusoh MR. Relapsed and late-onset Nipah encephalitis.. Ann Neurol 2002 Jun;51(6):703-8.
- Taylor C, Playford EG, McBride WJ, McMahon J, Warrilow D. No evidence of prolonged Hendra virus shedding by 2 patients, Australia.. Emerg Infect Dis 2012 Dec;18(12):2025-7.
- Young PL, Halpin K, Selleck PW, Field H, Gravel JL, Kelly MA, Mackenzie JS. Serologic evidence for the presence in Pteropus bats of a paramyxovirus related to equine morbillivirus.. Emerg Infect Dis 1996 Jul-Sep;2(3):239-40.
- Field H, Young P, Yob JM, Mills J, Hall L, Mackenzie J. The natural history of Hendra and Nipah viruses.. Microbes Infect 2001 Apr;3(4):307-14.
- Hutson T, Suyanto A, Helgen K, et al. Pteropus alecto. [Accessed 07 February 2013];IUCN 2013. IUCN Red List of Threatened Species. Version 2013.2. 2008 < www.iucnredlist.org>.
- Halpin K, Young PL, Field HE, Mackenzie JS. Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus.. J Gen Virol 2000 Aug;81(Pt 8):1927-1932.
- Smith I, Broos A, de Jong C, Zeddeman A, Smith C, Smith G, Moore F, Barr J, Crameri G, Marsh G, Tachedjian M, Yu M, Kung YH, Wang LF, Field H. Identifying Hendra virus diversity in pteropid bats.. PLoS One 2011;6(9):e25275.
- Williamson MM, Hooper PT, Selleck PW, Gleeson LJ, Daniels PW, Westbury HA, Murray PK. Transmission studies of Hendra virus (equine morbillivirus) in fruit bats, horses and cats.. Aust Vet J 1998 Dec;76(12):813-8.
- Williamson MM, Hooper PT, Selleck PW, Westbury HA, Slocombe RF. Experimental hendra virus infectionin pregnant guinea-pigs and fruit Bats (Pteropus poliocephalus).. J Comp Pathol 2000 Feb-Apr;122(2-3):201-7.
- Halpin K, Hyatt AD, Fogarty R, Middleton D, Bingham J, Epstein JH, Rahman SA, Hughes T, Smith C, Field HE, Daszak P. Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission.. Am J Trop Med Hyg 2011 Nov;85(5):946-51.
- Field H, de Jong C, Melville D, Smith C, Smith I, Broos A, Kung YH, McLaughlin A, Zeddeman A. Hendra virus infection dynamics in Australian fruit bats.. PLoS One 2011;6(12):e28678.
- Selvey LA, Wells RM, McCormack JG, Ansford AJ, Murray K, Rogers RJ, Lavercombe PS, Selleck P, Sheridan JW. Infection of humans and horses by a newly described morbillivirus.. Med J Aust 1995 Jun 19;162(12):642-5.
- Baldock FC, Douglas IC, Halpin K, et al. Epidemiological investigations into the 1994 equine morbillivirus outbreaks in Queensland, Australia. Singapore Vet J. 1996;20:57u201361.
- Rogers RJ, Douglas IC, Baldock FC, Glanville RJ, Seppanen KT, Gleeson LJ, Selleck PN, Dunn KJ. Investigation of a second focus of equine morbillivirus infection in coastal Queensland.. Aust Vet J 1996 Sep;74(3):243-4.
- Field H, Schaaf K, Kung N, Simon C, Waltisbuhl D, Hobert H, Moore F, Middleton D, Crook A, Smith G, Daniels P, Glanville R, Lovell D. Hendra virus outbreak with novel clinical features, Australia.. Emerg Infect Dis 2010 Feb;16(2):338-40.
- Marsh GA, Haining J, Hancock TJ, Robinson R, Foord AJ, Barr JA, Riddell S, Heine HG, White JR, Crameri G, Field HE, Wang LF, Middleton D. Experimental infection of horses with Hendra virus/Australia/horse/2008/Redlands.. Emerg Infect Dis 2011 Dec;17(12):2232-8.
- Marsh GA, Todd S, Foord A, Hansson E, Davies K, Wright L, Morrissy C, Halpin K, Middleton D, Field HE, Daniels P, Wang LF. Genome sequence conservation of Hendra virus isolates during spillover to horses, Australia.. Emerg Infect Dis 2010 Nov;16(11):1767-9.
- Hooper PT, Ketterer PJ, Hyatt AD, Russell GM. Lesions of experimental equine morbillivirus pneumonia in horses.. Vet Pathol 1997 Jul;34(4):312-22.
- [Accessed March 14, 2014];Guidelines for veterinarians handling potential Hendra virus infection in horses Version 5.0. 2013. Available at: http://www.daff.qld.gov.au/__data/assets/pdf_file/0009/97713/2355-guidelines-for-veterinarians-sept-2013.pdf.
- Degeling C, Kerridge I. Hendra in the news: public policy meets public morality in times of zoonotic uncertainty.. Soc Sci Med 2013 Apr;82:156-63.
- Mendez DH, Judd J, Speare R. Unexpected result of Hendra virus outbreaks for veterinarians, Queensland, Australia.. Emerg Infect Dis 2012 Jan;18(1):83-5.
- Bossart KN, Crameri G, Dimitrov AS, Mungall BA, Feng YR, Patch JR, Choudhary A, Wang LF, Eaton BT, Broder CC. Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.. J Virol 2005 Jun;79(11):6690-702.
- Mungall BA, Middleton D, Crameri G, Bingham J, Halpin K, Russell G, Green D, McEachern J, Pritchard LI, Eaton BT, Wang LF, Bossart KN, Broder CC. Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine.. J Virol 2006 Dec;80(24):12293-302.
- McEachern JA, Bingham J, Crameri G, Green DJ, Hancock TJ, Middleton D, Feng YR, Broder CC, Wang LF, Bossart KN. A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats.. Vaccine 2008 Jul 23;26(31):3842-52.
- Pallister J, Middleton D, Wang LF, Klein R, Haining J, Robinson R, Yamada M, White J, Payne J, Feng YR, Chan YP, Broder CC. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge.. Vaccine 2011 Aug 5;29(34):5623-30.
- Middleton D, Pallister J, Klein R, Feng YR, Haining J, Arkinstall R, Frazer L, Huang JA, Edwards N, Wareing M, Elhay M, Hashmi Z, Bingham J, Yamada M, Johnson D, White J, Foord A, Heine HG, Marsh GA, Broder CC, Wang LF. Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health.. Emerg Infect Dis 2014 Mar;20(3):372-9.
- Zhu Z, Bossart KN, Bishop KA, Crameri G, Dimitrov AS, McEachern JA, Feng Y, Middleton D, Wang LF, Broder CC, Dimitrov DS. Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody.. J Infect Dis 2008 Mar 15;197(6):846-53.
- Bossart KN, Zhu Z, Middleton D, Klippel J, Crameri G, Bingham J, McEachern JA, Green D, Hancock TJ, Chan YP, Hickey AC, Dimitrov DS, Wang LF, Broder CC. A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.. PLoS Pathog 2009 Oct;5(10):e1000642.
- Bossart KN, Geisbert TW, Feldmann H, Zhu Z, Feldmann F, Geisbert JB, Yan L, Feng YR, Brining D, Scott D, Wang Y, Dimitrov AS, Callison J, Chan YP, Hickey AC, Dimitrov DS, Broder CC, Rockx B. A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge.. Sci Transl Med 2011 Oct 19;3(105):105ra103.
- Hooper PT, Westbury HA, Russell GM. The lesions of experimental equine morbillivirus disease in cats and guinea pigs.. Vet Pathol 1997 Jul;34(4):323-9.
- Westbury HA, Hooper PT, Brouwer SL, Selleck PW. Susceptibility of cats to equine morbillivirus.. Aust Vet J 1996 Aug;74(2):132-4.
- Guillaume V, Wong KT, Looi RY, Georges-Courbot MC, Barrot L, Buckland R, Wild TF, Horvat B. Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model.. Virology 2009 May 10;387(2):459-65.
- Li M, Embury-Hyatt C, Weingartl HM. Experimental inoculation study indicates swine as a potential host for Hendra virus.. Vet Res 2010 May-Jun;41(3):33.
- Dups J, Middleton D, Yamada M, Monaghan P, Long F, Robinson R, Marsh GA, Wang LF. A new model for Hendra virus encephalitis in the mouse.. PLoS One 2012;7(7):e40308.
- Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P. Global trends in emerging infectious diseases.. Nature 2008 Feb 21;451(7181):990-3.
Citations
This article has been cited 22 times.- Anderson C, Baha H, Boghdeh N, Barrera M, Alem F, Narayanan A. Interactions of Equine Viruses with the Host Kinase Machinery and Implications for One Health and Human Disease.. Viruses 2023 May 13;15(5).
- Su H, Wang Y, Han Y, Jin Q, Yang F, Wu Z. Discovery and characterization of novel paramyxoviruses from bat samples in China.. Virol Sin 2023 Apr;38(2):198-207.
- Bruno L, Nappo MA, Ferrari L, Di Lecce R, Guarnieri C, Cantoni AM, Corradi A. Nipah Virus Disease: Epidemiological, Clinical, Diagnostic and Legislative Aspects of This Unpredictable Emerging Zoonosis.. Animals (Basel) 2022 Dec 31;13(1).
- Harvey AM, Ramp D, Mellor DJ. Review of the Foundational Knowledge Required for Assessing Horse Welfare.. Animals (Basel) 2022 Dec 1;12(23).
- Taylor J, Thompson K, Annand EJ, Massey PD, Bennett J, Eden JS, Horsburgh BA, Hodgson E, Wood K, Kerr J, Kirkland P, Finlaison D, Peel AJ, Eby P, Durrheim DN. Novel variant Hendra virus genotype 2 infection in a horse in the greater Newcastle region, New South Wales, Australia.. One Health 2022 Dec;15:100423.
- Lawrence P, Escudero-Pu00e9rez B. Henipavirus Immune Evasion and Pathogenesis Mechanisms: Lessons Learnt from Natural Infection and Animal Models.. Viruses 2022 Apr 29;14(5).
- Kummer S, Kranz DC. Henipaviruses-A constant threat to livestock and humans.. PLoS Negl Trop Dis 2022 Feb;16(2):e0010157.
- Lewis CE, Pickering B. Livestock and Risk Group 4 Pathogens: Researching Zoonotic Threats to Public Health and Agriculture in Maximum Containment.. ILAR J 2022 Jan 7;61(1):86-102.
- Gern OL, Mulenge F, Pavlou A, Ghita L, Steffen I, Stangel M, Kalinke U. Toll-like Receptors in Viral Encephalitis.. Viruses 2021 Oct 14;13(10).
- Amaya M, Broder CC. Vaccines to Emerging Viruses: Nipah and Hendra.. Annu Rev Virol 2020 Sep 29;7(1):447-473.
- Liang B. Structures of the Mononegavirales Polymerases.. J Virol 2020 Oct 27;94(22).
- Altan E, Li Y, Sabino-Santos G Jr, Sawaswong V, Barnum S, Pusterla N, Deng X, Delwart E. Viruses in Horses with Neurologic and Respiratory Diseases.. Viruses 2019 Oct 14;11(10).
- Di Rubbo A, McNabb L, Klein R, White JR, Colling A, Dimitrov DS, Broder CC, Middleton D, Lunt RA. Optimization and diagnostic evaluation of monoclonal antibody-based blocking ELISA formats for detection of neutralizing antibodies to Hendra virus in mammalian sera.. J Virol Methods 2019 Dec;274:113731.
- Barba M, Fairbanks EL, Daly JM. Equine viral encephalitis: prevalence, impact, and management strategies.. Vet Med (Auckl) 2019;10:99-110.
- Sun B, Jia L, Liang B, Chen Q, Liu D. Phylogeography, Transmission, and Viral Proteins of Nipah Virus.. Virol Sin 2018 Oct;33(5):385-393.
- Kumar B, Manuja A, Gulati BR, Virmani N, Tripathi BN. Zoonotic Viral Diseases of Equines and Their Impact on Human and Animal Health.. Open Virol J 2018;12:80-98.
- Fischer K, Diederich S, Smith G, Reiche S, Pinho Dos Reis V, Stroh E, Groschup MH, Weingartl HM, Balkema-Buschmann A. Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs.. PLoS One 2018;13(4):e0194385.
- Goyen KA, Wright JD, Cunneen A, Henning J. Playing with fire - What is influencing horse owners' decisions to not vaccinate their horses against deadly Hendra virus infection?. PLoS One 2017;12(6):e0180062.
- Burroughs AL, Durr PA, Boyd V, Graham K, White JR, Todd S, Barr J, Smith I, Baverstock G, Meers J, Crameri G, Wang LF. Hendra Virus Infection Dynamics in the Grey-Headed Flying Fox (Pteropus poliocephalus) at the Southern-Most Extent of Its Range: Further Evidence This Species Does Not Readily Transmit the Virus to Horses.. PLoS One 2016;11(6):e0155252.
- Modjarrad K. MERS-CoV vaccine candidates in development: The current landscape.. Vaccine 2016 Jun 3;34(26):2982-2987.
- Parvege MM, Rahman M, Nibir YM, Hossain MS. Two highly similar LAEDDTNAQKT and LTDKIGTEI epitopes in G glycoprotein may be useful for effective epitope based vaccine design against pathogenic Henipavirus.. Comput Biol Chem 2016 Apr;61:270-80.
- Conceiu00e7u00e3o-Neto N, Zeller M, Heylen E, Lefru00e8re H, Mesquita JR, Matthijnssens J. Fecal virome analysis of three carnivores reveals a novel nodavirus and multiple gemycircularviruses.. Virol J 2015 May 20;12:79.